ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 9 of 41
Up
JMBS 2017, 2(3): 48–55
https://doi.org/10.26693/jmbs02.03.048
Clinical Medicine

Mechanisms of Immune Inflammation Formation in Bro-Nchial Asthma, Combined with Metabolically Important States: Obesity or Diabetes Mellitus Type II

Yeryomenko G.
Abstract

Aim: To conduct the study of the formation mechanisms of immune inflammation in patients with asthma, asthma-associated obesity, and asthma in association with type II diabetes mellitus (DM). Materials and methods: 155 patients who were divided into 3 groups - with BA - I group (32), asthma and obesity - II group (52), asthma and DM type II - III group (71) were examined. In all patients the parameters of cellular and humoral immunity phagocytic activity of neutrophils were studied. Results. In patients with asthma, asthma, asthma and obesity, asthma associated with type II DM indicates the formation of a deficiency in the cellular immunity, the severity of which was most significant in patients with asthma associated with type 2 DM. All patients had dysfunction of phagocytic cells, which was most significant in asthma associated with type II DM. In patients with asthma and asthma, combined with obesity, activation of nonspecific and specific components of the humoral immune response was noted. In patients with asthma associated with type 2 diabetes, the lack of specificity with a decrease in IgE is observed with the strain of nonspecific immunity. The increase in the level of lymphocytic antibodies in the blood of patients with asthma associated with obesity and asthma associated with type 2 diabetes, along with a decrease in the total number of circulated immune complexes (CIC), indicates the formation of an autoimmune component of inflammation in the comorbidity of asthma and obesity, and may adversely affect changes in cellular unit of immunity. Conclusions: The decrease in IgE level in patients with asthma associated with type II diabetes, along with an increase in the number of lymphocyte autoantibodies, indicates pathogenic changes in the combination of asthma with the most metabolically significant disease: a decrease in the severity of the allergic component of inflammation and its replacement by an autoimmune, which is more aggressive.

Keywords: asthma, obesity, diabetes mellitus type II, cellular and humoral immunity

Full text: PDF (Ukr) 228K

References
  1. Frolov V.M., Pinskiy L.L., Peresadin N.A., Veksler Kh.M. Autoimmunnaya i immunokompleksnaya patologiya u bolnykh sakharnym diabetom. Problemy endokrinologii. 1991; 37 (5): 22-4. [Russian].
  2. Belyalov FI. Lechenie vnutrennikh bolezney v usloviyakh komorbidnosti. Irkutsk: RIO IGIUVa; 2011. 305 s. [Russian].
  3. Bikova-Truedsson NI. Stan klitinnoyi lanki imunitetu u khvorikh z khronichnim nekalkuloznim kholetsistitom na tli tsukrovogo diabetu II tipu. Ukr morfologichniy almanakh. 2009; 7 (3): 15-7. [Ukrainian].
  4. Bikova Truedsson NI. Stan sistemi fagotsituyuchikh makrofagiv u khvorikh na khronichniy nekalkulozniy kholetsistit na tli tsukrovogo diabetu II tipu. Problemi ekologichnoyi ta medichnoyi genetiki i klinichnoyi imunologiyi: zb nauk prats Kiyiv-Lugansk-Kharkiv. 2009; 5-6 (86-87): 112-9. [Ukrainian].
  5. Vertkin AL, Khovasova NO. Komorbidnost – novaya patologiya. Tekhnologiya eyo profilaktiki i lecheniya. Arkhiv vnutrenney meditsiny. 2013; 4: 68–72. [Russian].
  6. Drannik GN. Klinicheskaya immunologiya i allergologiya. K: Izdatelstvo OOO «Poligraf Plyus»; 2006. 482 s. [Russian].
  7. Kobylyanskiy VI, Babadzhanova GYu, Suntsov YuI. Izuchenie svyazey mezhdu khronicheskoy obstruktivnoy boleznyu legkikh, bronkhialnoy astmoy i sakharnym diabetom II tipa. Klinicheskaya meditsina. 2009; 12: 40–3. [Russian].
  8. Lazutkina EL, Lazarenko LL, Bardov VS. Pokazateli gumoralnogo i kletochnogo immuniteta u bolnykh bronkhialnoy astmoy. Sb trudov XXVI Nats Kongressa po boleznyam organov dykhaniya. Moskva; 2016. s. 33–4. [Russian].
  9. Ogorodova LM, Kulikov ES, Timoshina EL. Ozhirenie i bronkhialnaya astma: novyi vzglyad (obzor). Terapevticheskiy arkhiv. 2007; 10: 32-5. [Russian].
  10. Pobedonna GP. Sistemni porushennya klitinnogo metabolizmu u khvorikh na bronkhialnu astmu: klinichne znachennya i suchasni metodi terapiyi: avtoref. diss. … doktora med. nauk. Abstr. Dr. Sci. (Med.). Kiyiv; 2007. 24 s. [Ukrainian].
  11. Pobedonna GP, Revunova NV, Andreyeva ZB, ta in. Pokazniki stanu imunnoyi sistemi khvorikh na bronkhialnu astmu riznikh stupeniv tyazhkosti. Materiali III Nats Astma-kongresu: Kiyiv, 2009; 1-2: 67-70. [Ukrainian].
  12. Pristupa LN. Vzayemne obtyazhennya. Suchasne uyavlennya pro vzayemozv’yazok bronkhialnoyi astmi ta komponentiv metabolichnogo sindromu. Liki Ukrayini. 2005; 7/8 (96–97): 28–30. [Ukrainian].
  13. Skorokhodkina OV, Luntsov AV. Kharakteristika sindroma vtorichnoy immunnoy nedostatochnosti i vozmozhnosti ego korrektsii u patsientov v mnogoprofilnom statsionare. Prakticheskaya meditsina. 2012; 4 (59): 132–6. [Russian].
  14. Skripnik NV. Imunologichni osnovi metabolichnogo sindromu. Arkhiv klinichnoyi meditsini. 2009; 1 (15): 80-4. [Ukrainian].
  15. Tkachenko PI. Stan imunologichnoyi rezistentnosti u khvorikh na tsukroviy diabet 2 tipu, yaki potrebuyut khirurgichnoyi sanatsiyi porozhnini rota. Ukrayinskiy stomatologichniy almanakh: naukovo-praktichniy retsenzovaniy zhurnal. 2009; 5: 19–23. [Ukrainian].
  16. Chernushenko KF. Imunopatogenez bronkhialnoyi astmi. Nova meditsina. 2003; 1 (6): 18–-21. [Ukrainian].
  17. Feshchenko YuI. Bronkhoobstruktivni zakhvoryuvannya: suchasniy stan problemi. Zdorov’ya Ukrayini. 2011; 4 (16): 8–10. [Ukrainian].
  18. Yashina LA. Izbytochnaya massa tela, ozhirenie i patologiya legkikh: vzglyad pulmonologa. Zdorov'ya Ukraïni. 2011 Kviten; 14–5. [Russian].
  19. Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem. 2012 Dec; 68 (4): 701–11. https://www.ncbi.nlm.nih.gov/pubmed/22351038. https://doi.org/10.1007/s13105-012-0154-2
  20. Yeh KH, Skowronski ME, Coreno AJ, Seitz RE, Villalba KD, Dickey-White H, McFadden ER. Impact of Obesity on the Severity and Therapeutic Responsiveness of Acute Episodes of Asthma. J Asthma. 2011 Aug; 48 (6): 546–52. https://www.ncbi.nlm.nih.gov/pubmed/21604921. https://doi.org/10.3109/02770903.2011.581733
  21. Sood A, Camargo ES, Ford CA. Association between leptin and asthma in adults. Thorax. 2006; 61: 300–5. https://www.ncbi.nlm.nih.gov/pmc/articles/2104595. https://doi.org/10.1136/thx.2004.031468
  22. Vortmann M, Eisner MD.. BMI and health status among adults with asthma. Obesity (Silver Spring). 2008 Jan; 16 (1): 146–52. https://www.ncbi.nlm.nih.gov/pubmed/18223627. https://doi.org/10.1038/oby.2007.7